Skip to Content

Investor Relations

BioScrip®, Inc. is the largest independent national provider of infusion and home care management solutions, with approximately 2,200 teammates and nearly 80 service locations across the U.S...
Read More

Corporate Profile

BioScrip®, Inc. is the largest independent national provider of infusion and home care management solutions, with approximately 2,200 teammates and nearly 80 service locations across the U.S. BioScrip partners with physicians, hospital systems, payors, pharmaceutical manufacturers and skilled nursing facilities to provide patients access to post-acute care services. BioScrip operates with a commitment to bring customer-focused pharmacy and related healthcare infusion therapy services into the home or alternate-site setting. By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by clinical excellence, customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves.

Investor Overview

News Releases

Date Title and Summary
Toggle Summary BioScrip Timely Files Annual Form 10-K, Concludes Accounting Review and Provides Update on Immaterial Financial Statement Corrections
DENVER , March 26, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company has filed timely its Annual Report on Form 10-K for the year ended
Toggle Summary BioScrip Provides Update on Annual Form 10-K Filing Status
DENVER --(BUSINESS WIRE)--Mar. 15, 2018-- BioScrip, Inc. (NASDAQ: BIOS) (" BioScrip " or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that it will be filing a Form 12b-25 with the U.S.
Toggle Summary BioScrip Reports Fourth Quarter and Full Year 2017 Financial Results
DENVER --(BUSINESS WIRE)--Mar. 8, 2018-- BioScrip, Inc. (NASDAQ: BIOS) (" BioScrip " or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced its preliminary 2017 financial results and provided financial guidance for 2018, subject